Toripalimab Combined With S1 and Albumin Paclitaxel in Patients With Advanced Biliary Tract Cancer
Status:
Unknown status
Trial end date:
2021-05-01
Target enrollment:
Participant gender:
Summary
The investigator's study is a single armed phrase II trial ,aiming to improve the effecacy of
treatment for advanced billiary tract cancer by means of Toripalimab combining with S1 and
Albumin Paclitaxel as first line in patients with advanced Biliary Tract Cancer. treatment
continually until disease progression or intolerable toxicity or Patients withdrawal of
consent.and target sample is 30+ patients.